Supernus Pharmaceuticals
SUPN
SUPN
243 hedge funds and large institutions have $1.56B invested in Supernus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 86 increasing their positions, 80 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 249 → 243 (-6)
19% less capital invested
Capital invested by funds: $1.93B → $1.56B (-$370M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
243
Holding in Top 10
1
Calls
$1.29M
Puts
$352K
Top Buyers
| 1 | +$49.3M | |
| 2 | +$39.1M | |
| 3 | +$11.4M | |
| 4 |
Renaissance Technologies
New York
|
+$10.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.98M |
Top Sellers
| 1 | -$44M | |
| 2 | -$29.7M | |
| 3 | -$12.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.5M |
| 5 |
CWM
Congress Wealth Management
Boston,
Massachusetts
|
-$6.06M |